Warfarin therapy does not increase risk of symptomatic intracerebral hemorrhage in eligible patients after intravenous thrombolysis.

Levin, Dimitriy

Warfarin therapy does not increase risk of symptomatic intracerebral hemorrhage in eligible patients after intravenous thrombolysis. [electronic resource] - Archives of neurology Jan 2011 - 135; author reply 135-6 p. digital

Publication Type: Comment; Letter; Research Support, U.S. Gov't, Non-P.H.S.

1538-3687

10.1001/archneurol.2010.323 doi


Cerebral Hemorrhage--chemically induced
Humans
Injections, Intravenous
Risk Factors
Thrombolytic Therapy
Tissue Plasminogen Activator--administration & dosage
Warfarin--administration & dosage